CANCER drug treatments are under scrutiny as a cause of soaring healthcare and claims costs. Current cancer patients will have to brace for changes.
Home Investments Fine-tuning MediShield Life: From 2022, cancer drug treatments must be in “positive...
Recent Posts
Most Popular
Blockchain billionaire emerges from Figure’s post-IPO surge
It took him a few tries, but Mike Cagney is now a billionaire.